Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

Malawi holds the highest reported global age-standardized rate for esophageal squamous cell carcinoma (ESCC) incidence and ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...

Alcohol is a known risk factor for cancer, and new research is showing just how much it has impacted death rates in the past three decades.

ESCC accounts for nearly 90% of esophageal cancers globally with a five ... "Patients with metastatic esophageal squamous cell carcinoma continue to experience poor outcomes despite currently ...

“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant ... junction (G/GEJ) cancers. The Company recently announced its intent ...

1 According to the American Cancer Society, esophageal cancer is significantly ... “FDA approval of Tevimbra for the first-line treatment of advanced esophageal squamous cell carcinoma marks a ...